![clincloud](https://investor.igcpharma.com/wp-content/uploads/2024/04/PR-AD_03-min-1024x1024.jpg)
June 9, 2021
IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients
Facebook
Twitter
LinkedIn